PharOS MT Ltd. Pharos Pharmaceutical Oriented Services Ltd.
PolandAll medications by this manufacturer
-
Breluncol
Form: tablets, film-coated
Active substance Dosage brivaracetam 10 mg ATC: N03AX23
-
Breluncol
Form: tablets, film-coated
Active substance Dosage brivaracetam 25 mg ATC: N03AX23
-
Breluncol
Form: tablets, film-coated
Active substance Dosage Brivaracetam 50 mg ATC: N03AX23
-
Breluncol
Form: tablets, film-coated
Active substance Dosage brivaracetam 75 mg ATC: N03AX23
-
Breluncol
Form: tablets, film-coated
Active substance Dosage brivaracetam 100 mg ATC: N03AX23
-
Kymbek
Form: tablets, film-coated
Active substance Dosage edoxaban 15 mg ATC: B01AF03
-
Kymbek
Form: tablets, film-coated
Active substance Dosage edoxaban 30 mg ATC: B01AF03
-
Kymbek
Form: tablets, film-coated
Active substance Dosage edoxaban 60 mg ATC: B01AF03
-
Nilotinib viatris
Form: capsules, hard
Active substance Dosage nilotinib 50 mg ATC: L01EA03
-
Nilotinib viatris
Form: capsules, hard
Active substance Dosage nilotinib 150 mg ATC: L01EA03
-
Nilotinib viatris
Form: capsules, hard
Active substance Dosage nilotinib 200 mg ATC: L01EA03
-
Nilotinib zentiva
Form: capsules, hard
Active substance Dosage nilotinib 150 mg ATC: L01EA03
-
Nilotinib zentiva
Form: capsules, hard
Active substance Dosage nilotinib 200 mg ATC: L01EA03
-
Runaplax + asa
Form: capsules, hard
Active substance Dosage rivaroxaban 2.5 mg acetylsalicylic acid 50 mg ATC: B01AF51